medical journal report interleukin promise promise find controversial experimental drug call interleukin cure cancer publish issue prestigious england journal medicine accord wall street analyst obtain advance copy magazine interleukin principal maker cetus ctus headquarter emeryville calif immunex imnx base seattle wash journal release contain article report remission rate cancer type journal contain sign editorial conclude result mark significant milestone search successful immunotherapy cancer interleukin substance naturally produce live cell laboratory drug controversial widely praise promise cancer treatment report effectiveness criticism failure live promise due ravage effect study conduct dr william biotherapeutics franklin tenn particularly significant find fewer harsh effect change drug administer study researcher administer cancer patient find pct remission rate kidney cancer pct remission rate melanoma type cancer accord prudentialbache security stuart weisbrod obtain advance copy magazine rectal colon cancer researcher find remission none patient treat effect serious place intensive hospital care accord article study principal author dr steven rosenberg national cancer institute researcher administer cancer patient find pct remission rate cancer kidney pct rate melanoma pct rate cancer colon rectum national cancer institute trial total patient die magazine report confirm harshness drug effect originally administer begin search successful immunotherapy cancer editorial sign john durant philadelphia chase cancer center observation report rosenberg surely describe successful practical approach widespread application therapy cancer patient editorial hand reflect successful manipulation cellular immune system near search meaningful direction immunuotherapy cancer editorial conclude 
